|
PTGER4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13810080751387E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33699717963509E-11 |
| Normal-vs-Stage2 |
6.23070000038695E-08 |
| Normal-vs-Stage3 |
2.86670687188462E-12 |
| Normal-vs-Stage4 |
9.85889148097385E-12 |
| Stage1-vs-Stage2 |
1.288990E-01 |
| Stage1-vs-Stage3 |
5.788000E-01 |
| Stage1-vs-Stage4 |
3.548000E-01 |
| Stage2-vs-Stage3 |
9.433600E-02 |
| Stage2-vs-Stage4 |
5.075700E-02 |
| Stage3-vs-Stage4 |
6.018600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00539576664005E-11 |
| Normal-vs-AfricanAmerican |
2.94759772145881E-11 |
| Normal-vs-Asian |
9.13940034763527E-11 |
| Caucasian-vs-AfricanAmerican |
1.157770E-01 |
| Caucasian-vs-Asian |
8.527200E-01 |
| AfricanAmerican-vs-Asian |
7.329800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1654011916894E-11 |
| Normal-vs-Female |
1.24810162205335E-11 |
| Male-vs-Female |
7.528400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.07875988328988E-12 |
| Normal-vs-Extreme_Weight |
1.6261991753197E-11 |
| Normal-vs-Obese |
9.10116426666718E-12 |
| Normal-vs-Extreme_Obese |
6.41042774418565E-13 |
| Normal_Weight-vs-Extreme_Weight |
7.496400E-01 |
| Normal_Weight-vs-Obese |
8.796400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.959900E-03 |
| Extreme_Weight-vs-Obese |
8.960800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.961150E-04 |
| Obese-vs-Extreme_Obese |
6.958100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.18409726468371E-11 |
| Normal-vs-Age(41-60Yrs) |
1.47469814137935E-11 |
| Normal-vs-Age(61-80Yrs) |
1.1399992061456E-11 |
| Normal-vs-Age(81-100Yrs) |
2.79659961854861E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.355800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.240600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.071200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.854200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.935400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.027600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.56350488111912E-11 |
| Normal-VS-Type2 PRCC |
9.46909217702796E-12 |
| Normal-VS-KIRP CIMP |
5.94713167600958E-12 |
| Normal-VS-Unclassified PRCC |
3.0115998583824E-10 |
| Type1 PRCC-VS-Type2 PRCC |
7.295000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.190200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.613700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.211000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.034800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.907900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.32898203132027E-12 |
| Normal-vs-N1 |
4.20374846044069E-12 |
| Normal-vs-N2 |
1.23980004040902E-09 |
| N0-vs-N1 |
4.491000E-01 |
| N0-vs-N2 |
4.463400E-01 |
| N1-vs-N2 |
6.912000E-01 |
|
|
